Bimeda Announces Relaunch of Bimoxyl LA 150mg/ml Amoxicillin Suspension for Injection in New Shatterproof Bottle

Bimeda is pleased to announce the relaunch of their Bimoxyl LA 150mg/ml suspension for injection, containing 150mg/ml amoxicillin.

The product is licensed for use in cattle, sheep, pigs and dogs for the treatment of infections caused by amoxicillin-susceptible bacteria.

Bimeda UK General Manager, Mark Cokayne, commented, 'we are pleased to announce the relaunch of Bimoxyl LA Suspension for Injection. Bimoxyl LA is a category D antibiotic, which can be utilised as a first line treatment where necessary, in accordance with the European Medicine Agency's guidance on the prudent use of antibiotics.'

Key product features and benefits include;
  • Short milk withdrawal for dairy cattle of 72 hours
  • Short meat withdrawal periods of 19 days for sheep, 24 days for pigs and 21 days for cattle
  • Broad spectrum antibiotic with activity against gram-positive and gram-negative bacteria
  • Licensed for use in dogs
  • Shatterproof bottle

Mr Cokayne also spoke about the sustainability credentials of the product, noting, 'we are also pleased to announce that Bimoxyl LA will now be supplied in a shatterproof PET plastic bottle. This bottle is 79% lighter than the previous glass vial, requiring less energy for transportation and incineration. We have moved the site of manufacture for Bimoxyl LA from California to Europe, which also reduces the distance this product travels by over 5,000 miles.'

Bimoxyl LA is available in a 100ml pack size and is a category POM-V medicine.

For more information, speak to your Bimeda representative, order via your wholesaler or call Bimeda on 01248 725 400

Use Medicines Responsibly.
Full product information can be found on the package insert, the SPC which is located on the VMD website, or on the data sheet which is hosted at on Bimeda can be contacted on telephone on 01248 725400. Bimeda UK, Unit 2, Bryn Cefni Industrial Park, Llangefni, Anglesey, LL777XA.

Are Your Trace Element Supplementation Investments...
Bimeda acquires Afrivet